Synapse - Sujata Patil

Results (511)

Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer

Journal Article

Morris, P. G.; Lynch, C.; Feeney, J. N.; Patil, S.; Howard, J.; Larson, S. M.; Dickler, M.; Hudis, C. A.; Jochelson, M.; Mcarthur, H. L.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Minimal disease in the sentinel lymph node: How to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease

Journal Article

Kumar, S.; Bramlage, M.; Jacks, L. M.; Goldberg, J. I.; Patil, S. M.; Giri, D. D.; Van Zee, K. J.
Annals of Surgical Oncology (2010)

Fulltext@MSK | Save

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

Journal Article

Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
Investigational New Drugs (2010)

Fulltext@MSK | Save

Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer

Journal Article

Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
Clinical Breast Cancer (2010)

Fulltext@MSK | Save

Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea

Journal Article

Dang, C.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Morris, P.; Abbruzzi, A.; Chen, C.; Steingart, R.; Patil, S.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Impact of breast density on the presenting features of malignancy

Journal Article

Arora, N.; King, T. A.; Jacks, L. M.; Stempel, M. M.; Patil, S.; Morris, E.; Morrow, M.
Annals of Surgical Oncology (2010)

Fulltext@MSK | Save

Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab

Meeting Abstract

Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up

Meeting Abstract

Rudloff, U.; Brogi, E.; McCormick, B.; Brockway, J. P.; Goldberg, J. I.; Wynveen, C. A.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

The clinical impact and outcomes of immunohistochemistry-only metastases in breast cancer

Meeting Abstract

Pugliese, M. S.; Stempel, M. M.; Patil, S. M.; Hsu, M.; Cody, H. S. 3rd; Morrow, M.; Gemignani, M. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save